IDO‐1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.040896 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Zongye Cai und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou China. Hauptthemen laut MEDLINE: Vascular Remodeling, Indoleamine-Pyrrole 2,3,-Dioxygenase, Kynurenine, Pulmonary Artery. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Activation of the plasma kynurenine pathway (KP) may contribute to the progression of pulmonary arterial hypertension (PAH). We investigated the functional role and molecular mechanisms of KP activation in PAH.
Methods
KP activity was measured in the lungs and plasma of humans and rodents with pulmonary hypertension (PH). KP activity was modulated in lung microvascular endothelial cells in vitro, and through daily oral administration of epacadostat, an inhibitor of IDO‐1 (indoleamine 2,3‐dioxygenase), the rate‐limiting enzyme of the KP, in rats with monocrotaline‐induced PH.
Results
IDO‐1 expression was increased in peripheral blood mononuclear cells but not in lung tissue of patients with PAH and in rats with monocrotaline‐induced PH. Epacadostat prevented KP activation and the development of monocrotaline‐induced PH, significantly reduced right ventricular systolic pressure (58±9 versus 42±4 and 46±6 mm Hg for placebo versus epacadostat 50 and 100 mg/kg, respectively, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou China.
- Department of Cardiology Erasmus MC, University Medical Center Rotterdam The Netherlands.
- INSERM UMR_S 999, Hypertension Pulmonaire : Pathophysiologie et Innovation Thérapeutique (HPPIT) Le Kremlin-Bicêtre France.
- Université Paris-Saclay, School of Medicine, HPPIT Le Kremlin-Bicêtre France.
- Department of Cardiology The Eighth Affiliated Hospital of Sun Yat-sen University Shenzhen Guangdong China.
- Department of Pathology Erasmus MC, University Medical Center Rotterdam Netherlands.
ORCID-Profile: Zongye Cai, Siyu Tian, Lin Deng, Thierry P P van den Bosch, Bence M Nagy, Horst Olschewski, Yi Yan, Christophe Guignabert, Daphne Merkus
Zitieren
APA
Cai, Z., Tu, L., Tian, S., Deng, L., Fu, Y., Phan, C., van den Bosch, T. P. P., Tran-Lundmark, K., Nagy, B. M., Olschewski, H., Li, X., Wang, S., Wang, D., Yan, Y., Fu, L., Boomars, K. A., Guignabert, C., & Merkus, D. (2025). IDO‐1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.040896
Vancouver
Cai Z, Tu L, Tian S, Deng L, Fu Y, Phan C, et al. IDO‐1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.040896
BibTeX
@article{Cai2025,
author = {Cai, Zongye and Tu, Ly and Tian, Siyu and Deng, Lin and Fu, Yahong and Phan, Carole and van den Bosch, Thierry P P and Tran-Lundmark, Karin and Nagy, Bence M and Olschewski, Horst and Li, Xiaoxuan and Wang, Sihao and Wang, Danan and Yan, Yi and Fu, Lijun and Boomars, Karin A and Guignabert, Christophe and Merkus, Daphne},
title = {IDO‐1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.040896}
}
EUVIMED